Immunome, Inc. (IMNM)
19.20
-0.11
(-0.57%)
USD |
NASDAQ |
Oct 07, 15:50
Immunome Net Income (Quarterly) : -73.13M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -73.13M |
| March 31, 2026 | -53.84M |
| December 31, 2025 | -69.90M |
| September 30, 2025 | -57.46M |
| June 30, 2025 | -43.40M |
| March 31, 2025 | -41.64M |
| December 31, 2024 | -80.25M |
| September 30, 2024 | -47.10M |
| June 30, 2024 | -36.12M |
| March 31, 2024 | -129.49M |
| December 31, 2023 | -92.63M |
| September 30, 2023 | -4.345M |
| June 30, 2023 | -5.557M |
| March 31, 2023 | -4.27M |
| Date | Value |
|---|---|
| December 31, 2022 | -7.786M |
| September 30, 2022 | -8.533M |
| June 30, 2022 | -8.924M |
| March 31, 2022 | -11.65M |
| December 31, 2021 | -7.852M |
| September 30, 2021 | -7.72M |
| June 30, 2021 | -5.241M |
| March 31, 2021 | -3.898M |
| December 31, 2020 | -4.073M |
| September 30, 2020 | -8.377M |
| June 30, 2020 | -2.71M |
| March 31, 2020 | -2.677M |
| September 30, 2019 | -2.737M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Erasca, Inc. | -44.08M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 73.13M |
| EPS Diluted (Quarterly) | -0.6456 |
| Enterprise Value | 1.672B |
| Earnings Yield | -13.16% |
| Normalized Earnings Yield | -12.77 |